Medicare Enrolled
Dr. Paul Barone, D.O.
Cardiovascular Disease · Watchung, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barone from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barone?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barone
Dr. Paul Barone is a cardiovascular disease specialist in Watchung, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Barone performed 4,099 Medicare services across 3,164 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barone received a total of $8,452 from 37 pharmaceutical and/or device companies across 422 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barone is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 25% volume in NJ
$8,452 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,099
Medicare services
Top 25% in NJ for cardiovascular disease
3,164
Unique beneficiaries
$55
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~205 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,091 | $69 | $369 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
816 | $7 | $38 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
622 | $11 | $67 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
606 | $95 | $564 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
280 | $146 | $799 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $126 | $733 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
75 | $14 | $101 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
73 | $11 | $57 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
61 | $22 | $128 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
61 | $65 | $529 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
53 | $49 | $270 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
48 | $21 | $107 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
48 | $49 | $163 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
43 | $64 | $83 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
35 | $58 | $319 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
32 | $162 | $891 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
26 | $148 | $857 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
21 | $46 | $260 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
18 | $90 | $114 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
13 | $102 | $473 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.0% high complexity
2.9% medium
87.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,452
Total received (2018-2024)
Avg $1,207/year across 7 years
Top 24% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
422
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,452 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$989
2023
$1,131
2022
$1,247
2021
$1,065
2020
$123
2019
$2,807
2018
$1,089
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Ancora Heart, Inc.
$197
Amgen Inc.
$137
Merck Sharp & Dohme LLC
$102
E.R. Squibb & Sons, L.L.C.
$73
PFIZER INC.
$68
Azurity Pharmaceuticals, Inc.
$62
Esperion Therapeutics, Inc.
$58
Janssen Pharmaceuticals, Inc
$58
Novo Nordisk Inc
$48
AstraZeneca Pharmaceuticals LP
$44
SANOFI-AVENTIS U.S. LLC
$40
Novartis Pharmaceuticals Corporation
$32
ATRICURE, INC.
$22
Kowa Pharmaceuticals America, Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Kiniksa Pharmaceuticals International, plc
$14
Top 3 companies account for 44.1% of 2024 payments
All-time payments by company (2018-2024) ›
BIOTRONIK INC.
$1,739
Amgen Inc.
$812
Janssen Pharmaceuticals, Inc
$596
Impulse Dynamics (USA) Inc.
$590
Kowa Pharmaceuticals America, Inc.
$539
Merck Sharp & Dohme LLC
$428
AstraZeneca Pharmaceuticals LP
$331
Amarin Pharma Inc.
$328
E.R. Squibb & Sons, L.L.C.
$321
Novartis Pharmaceuticals Corporation
$297
PFIZER INC.
$289
SANOFI-AVENTIS U.S. LLC
$284
Abbott Laboratories
$252
Ancora Heart, Inc.
$197
Esperion Therapeutics, Inc.
$157
Boehringer Ingelheim Pharmaceuticals, Inc.
$149
Gilead Sciences, Inc.
$136
Novo Nordisk Inc
$127
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$111
Regeneron Healthcare Solutions, Inc.
$105
Alnylam Pharmaceuticals Inc.
$87
Azurity Pharmaceuticals, Inc.
$62
Boston Scientific Corporation
$62
Kiniksa Pharmaceuticals, Ltd.
$57
Merck Sharp & Dohme Corporation
$56
ARBOR PHARMACEUTICALS, INC.
$53
BOSTON SCIENTIFIC CORPORATION
$51
Allergan Inc.
$45
Lexicon Pharmaceuticals, Inc.
$33
iRhythm Technologies, Inc.
$31
Noden Pharma USA Inc
$27
ATRICURE, INC.
$22
Medtronic Vascular, Inc.
$20
Chiesi USA, Inc.
$17
Althera Pharmaceuticals LLC
$14
Kiniksa Pharmaceuticals International, plc
$14
ABIOMED
$12
Top 3 companies account for 37.2% of all-time payments
Associated products mentioned in payments ›
ATRICLIP LAA EXCLUSION SYSTEM · AccuCinch · Arcalyst · Azure · BRILINTA · BYSTOLIC · Bidil · CAMZYOS · CHANTIX · CONFIRM RX · Corlanor · EDARBI · ELIQUIS · ENTRESTO · Edarbyclor · Ellipse ICD · FARXIGA · Fortify Assura · GENERAL THERAPIES · HeartMate · Impella · Inpefa · JARDIANCE · JOT DX · KENGREAL · LEQVIO · LIVALO · LifeVest · Livalo · MULTAQ · NEXLETOL · ONPATTRO · OPTIMIZER · Optimizer · Optimizer Smart System · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Quadra Assura CRT Defibrillator · Repatha · Roszet · Rybelsus · Saxenda · TEKTURNA · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · Wegovy · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
674
Per 100K population
194.7
County median income
$135,960
Nearest hospital
MOUNTAINVIEW BEHAVIORAL HOSPITAL
2.4 mi
2.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Barone is a clinical cardiology specialist, with above-average Medicare volume (top 25% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Barone experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Barone performed 1,091 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barone receive payments from pharmaceutical companies?
Yes. Dr. Barone received a total of $8,452 from 37 companies across 422 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barone's costs compare to other cardiologists in Watchung?
Dr. Barone's average Medicare payment per service is $55. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barone) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Watchung
Browse cardiologists in Watchung ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology